This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the medication REXULTI 3 MG TABLET 30S. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $4,726.64 and is a Firm Fixed Price Delivery Order type contract. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 3/16/25, 12:55 AM